CRISPR Therapeutics AG

News & Events

Press Releases

In The Media

1. CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310(TM) Targeting ANGPTL3

   GlobeNewswire MAY 6, 2025 4:01 PM EDT
   -Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglyceri...
   READ ARTICLE

2. CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

   GlobeNewswire APR 3, 2025 8:00 AM EDT
   ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP...
   READ ARTICLE

3. CRISPR Therapeutics Announces Transition of Chief Operating Officer

   GlobeNewswire MAR 26, 2025 4:01 PM EDT
   ZUG, Switzerland and BOSTON, March 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:...
   READ ARTICLE

4. CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

   GlobeNewswire FEB 26, 2025 8:00 AM EST
   ZUG, Switzerland and BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP)...
   READ ARTICLE

5. CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

   GlobeNewswire FEB 11, 2025 4:01 PM EST
   -2025 is poised to be a catalyst-rich year with key updates across several programs- -Ong...
   READ ARTICLE

6. CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

   GlobeNewswire JAN 29, 2025 8:00 AM EST
   ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP)...
   READ ARTICLE

7. CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

   GlobeNewswire JAN 13, 2025 7:00 AM EST
   -Ongoing launch of CASGEVY ® continues to gain momentum- -2025 is poised to be a...
   READ ARTICLE

8. CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

   GlobeNewswire JAN 8, 2025 8:30 AM EST
   ZUG, Switzerland and BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP)...
   READ ARTICLE

9. CRISPR Therapeutics Proposes New Appointment to the Board of Directors

   GlobeNewswire JAN 7, 2025 8:00 AM EST
   ZUG, Switzerland and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: ...
   READ ARTICLE

10. CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

    GlobeNewswire DEC 9, 2024 12:00 PM EST
    -Preliminary data demonstrate that CTX112 ™ has the potential to provide meaningful cl...
    READ ARTICLE